Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Buy
64
MLYS Quote, Financials, Valuation and Earnings
Last price:
$16.76
Seasonality move
:
-0.62%
Day range:
$16.15 - $17.35
52-week range:
$8.24 - $18.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.31x
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
25.93%
Market cap:
$1B
Revenue:
--
EPS (TTM):
-$3.64
Earnings Data
Next earnings date for MLYS
May 09
2025
Most recent earnings per share
-$0.98
Beat by $0.10
(Feb 12/2025)
Consensus Estimate
-$1.08
(Feb 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MLYS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | -- | -- | -- | -$1.03 | -- |
| 02/12/2025 | Q4 | -- | -- | -$0.98 | -$1.08 | $0.10 |
| 11/11/2024 | Q3 | -- | -- | -$1.13 | -$0.83 | -$0.30 |
| 08/13/2024 | Q2 | -- | -- | -$0.83 | -$0.70 | -$0.13 |
| 05/09/2024 | Q1 | -- | -- | -$0.70 | -$0.67 | -$0.03 |
| 03/21/2024 | Q4 | -- | -- | -$0.63 | -$0.83 | $0.20 |
| 11/07/2023 | Q3 | -- | -- | -$0.57 | -$0.76 | $0.19 |
| 08/07/2023 | Q2 | -- | -- | -$0.31 | -$0.72 | $0.41 |
| 05/15/2023 | Q1 | -- | -- | -$0.51 | -$0.89 | $0.38 |
| 03/15/2023 | Q4 | -- | -- | -$0.23 | -$1.72 | $1.49 |
| 09/30/2022 | Q3 | -- | -- | -$1.29 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$1.25 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.46 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$1.37 | -- | -- |
Mineralys Therapeutics Earnings Questions
-
How Much did Mineralys Therapeutics Generate in Revenue Last Quarter?
Mineralys Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Mineralys Therapeutics Beat Earnings Last Quarter?
Mineralys Therapeutics announced earnings per share of -$0.98 which represents a beat of analyst forecast a -$1.08 per share.
-
Is Mineralys Therapeutics Profitable?
Mineralys Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Mineralys Therapeutics EPS Next Year?
Mineralys Therapeutics's earnings are forecast to decrease from -$3.66 per share to -$3.71 per share next year representing a decrease of -6.33%.
-
When is Mineralys Therapeutics's Earnings Date?
Mineralys Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Chevron Acquire Hess?
Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…
Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 1.01% over the past day.
Sell
36
MPTI alert for Mar 25
M-Tron Industries [MPTI] is up 7.48% over the past day.
